Zoetis Inc. Class A Common Stock (ZTS)
Stock · NYSE · Health Care
$77.34as of 8/28/2026
Price chart
Open in TradingViewActive signals
About ZTS
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 14,500
- Website
- www.zoetis.com/
Fundamentals
- 1-day range
- $75.2$77.71
- Market cap
- $32.32B
- P/E (trailing)
- 11.54
- P/E (forward)
- 11.84
- EPS (trailing)
- $6.08
- Dividend yield
- 1.64%
- Beta
- 0.73
- Avg. volume
- 6.52M
- Ex-dividend date
- July 20, 2026
- Dividend pay date
- September 1, 2026
How Zoetis Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 12, 2026 · via SEC EDGAR / Finnhub
Forecasts
15 analyst ratings
Zoetis Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- ZTSZoetis Inc. Class A Common Stock$77.36▲ 3.12%Market cap $32.32BP/E 11.54$71$156.49
- ONCBeOne Medicines Ltd. American Depositary Shares$366.79▼ 1.53%Market cap $34.88BP/E 88.12$205.51$346
- ROIVRoivant Sciences Ltd. Common Shares$34.71▼ 7.64%Market cap $24.08BP/E —$11.85$37.97
- UTHRUnited Therapeutics Corporation Common Stock$515.57▼ 2.34%Market cap $21.92BP/E 17.03$302.19$609.35
- INSMInsmed Incorporated Common Stock$118.52▼ 2.36%Market cap $21.34BP/E —$90.39$212.75
- VTRSViatris Inc. Common Stock$16.34▼ 3.26%Market cap $20.53BP/E —$9.43$18.39
- JAZZJazz Pharmaceuticals plc Common Stock (Ireland)$244.6▼ 2.59%Market cap $15.80BP/E 16.97$123.88$266.38
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ZTS Zoetis Inc. Class A Common Stock | $32.32B | 11.54 | $77.36 | ▲ 3.12% | $71$156.49 |
| ONC BeOne Medicines Ltd. American Depositary Shares | $34.88B | 88.12 | $366.79 | ▼ 1.53% | $205.51$346 |
| ROIV Roivant Sciences Ltd. Common Shares | $24.08B | — | $34.71 | ▼ 7.64% | $11.85$37.97 |
| UTHR United Therapeutics Corporation Common Stock | $21.92B | 17.03 | $515.57 | ▼ 2.34% | $302.19$609.35 |
| INSM Insmed Incorporated Common Stock | $21.34B | — | $118.52 | ▼ 2.36% | $90.39$212.75 |
| VTRS Viatris Inc. Common Stock | $20.53B | — | $16.34 | ▼ 3.26% | $9.43$18.39 |
| JAZZ Jazz Pharmaceuticals plc Common Stock (Ireland) | $15.80B | 16.97 | $244.6 | ▼ 2.59% | $123.88$266.38 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- TD Cowen Maintains Buy on Zoetis, Lowers Price Target to $94benzinga · 8/25/2026
- 3 of Wall Street’s Favorite Stocks We’re Skeptical OfYahoo · 8/21/2026
- 10 Health Care Stocks Whale Activity In Today’s SessionBenzinga · 8/21/2026
- Hedging Exposure In This Volatile MarketSeekingAlpha · 8/20/2026
- Stifel Maintains Hold on Zoetis, Lowers Price Target to $80Benzinga · 8/20/2026
- Zoetis (ZTS) Stock Still Looks Cheap After a 62% SlideYahoo · 8/19/2026
- Is Zoetis’ Lowered 2026 Outlook and Simparica Trio EUA Altering The Investment Case For Zoetis (ZTS)?Yahoo · 8/19/2026
- 3 High-Yielding Dividend Stocks That Have Doubled Their Payouts in 5 YearsYahoo · 8/19/2026
- GE HealthCare names new CFOYahoo · 8/19/2026
Insider Activity
Insider Actions →- Frank A. Damelio · August 7, 2026 · Gift6.7K
- Keith Sarbaugh · July 10, 2026 · Grant260 @ $26.22
- Nayak Abhay U · July 10, 2026 · Grant215 @ $26.22
- Kevin Esch · July 10, 2026 · Grant308 @ $26.22
- Rimma Driscoll · July 10, 2026 · Grant238 @ $26.22
- FULLER JULIE · July 10, 2026 · Grant315 @ $26.22
- Lagano Roxanne · July 10, 2026 · Grant315 @ $26.22
- Ferran Astorga Jeannette · July 10, 2026 · Grant45 @ $26.22
- Kristin C. Peck · July 10, 2026 · Grant616 @ $26.22
- Joseph Wetteny · July 10, 2026 · Grant363 @ $26.22
- Mark Stetter · June 18, 2026 · Grant318 @ $78.71
- Michael B. McCallister · June 10, 2026 · Gift1.2K
- Mark Stetter · May 21, 2026 · Option Exercise1.6K
- Louise M. Parent · May 20, 2026 · Option Exercise10.2K
- Louise M. Parent · May 20, 2026 · Option Exercise1.9K
Institutional Ownership
March 31, 2026
- Total shares held
- 377.95M
- Total value held
- $43.21B
- Institutional holders
- 1575
- Unknown35.58M
- Unknown26.07M
- Unknown19.32M
- Unknown15.89M
- Unknown14.15M
- Unknown11.35M
- Unknown10.15M
- Unknown5.87M
- Unknown5.66M
- Unknown5.55M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 30, 2026
Zoetis Gets Lowered Price Target as Analysts Reassess Animal Health Outlook. TD Cowen kept its positive stance on Zoetis but cut its price target from a higher level to $94, according to a Benzinga report. The move suggests the firm sees somewhat limited upside from current levels. Separately, Seeking Alpha featured Zoetis among healthcare dividend stocks highlighted for income-focused investors, noting its dividend yield and consistent payout history. The stock has traded within a wide 52-week range, and the revised target sits below the analyst average of $104.19.